Total Funding
71
54
Total FundingSeries A raised
Growth Score
-1 pts
Heat Score
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
36454
FELIQS is a research-based start-up that specializes in pharmaceutical sciences.
- Kenichiro Kuninobu: Co-Founder, Representative Director, and Chief Executive OfficerPast Role: Nipro Corporation, Manager, Regenerative Advanced Therapy
- Matt Fowler: CFO
About the Company
FELIQS is a preclinical-stage start-up company established based on the robust science from molecular pathobiology, department of pharmaceutical science, Kyushu university. The company develops therapies for neonatal eye disorders and vision preservation. The company combines translational research, academic partnerships, regulatory capabilities,
and cross-border collaboration to advance its programs. Its activities include drug development and patient-focused approaches that support ophthalmic care from early stages of life.
